AU2003277416A1 - Clofarabine and platinum chemotherapy combination - Google Patents
Clofarabine and platinum chemotherapy combinationInfo
- Publication number
- AU2003277416A1 AU2003277416A1 AU2003277416A AU2003277416A AU2003277416A1 AU 2003277416 A1 AU2003277416 A1 AU 2003277416A1 AU 2003277416 A AU2003277416 A AU 2003277416A AU 2003277416 A AU2003277416 A AU 2003277416A AU 2003277416 A1 AU2003277416 A1 AU 2003277416A1
- Authority
- AU
- Australia
- Prior art keywords
- clofarabine
- chemotherapy combination
- platinum chemotherapy
- platinum
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41906402P | 2002-10-16 | 2002-10-16 | |
US60/419,064 | 2002-10-16 | ||
PCT/US2003/032889 WO2004035043A1 (en) | 2002-10-16 | 2003-10-14 | Clofarabine and platinum chemotherapy combination |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003277416A1 true AU2003277416A1 (en) | 2004-05-04 |
Family
ID=32108020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003277416A Abandoned AU2003277416A1 (en) | 2002-10-16 | 2003-10-14 | Clofarabine and platinum chemotherapy combination |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003277416A1 (en) |
WO (1) | WO2004035043A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1875936B (en) * | 2006-07-18 | 2010-05-19 | 济南康泉医药科技有限公司 | Anticancer sustained release agent containing clorfarabine and cytotoxic drug |
US10987372B2 (en) * | 2016-03-11 | 2021-04-27 | Kagoshima University | Anti-hepatoma-virus agent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5562925A (en) * | 1970-04-20 | 1996-10-08 | Research Corporation Tech. Inc. | Anti-tumor method |
JPS6041077B2 (en) * | 1976-09-06 | 1985-09-13 | 喜徳 喜谷 | Cis platinum(2) complex of 1,2-diaminocyclohexane isomer |
US5384310A (en) * | 1989-05-23 | 1995-01-24 | Southern Research Institute | 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions |
-
2003
- 2003-10-14 WO PCT/US2003/032889 patent/WO2004035043A1/en not_active Application Discontinuation
- 2003-10-14 AU AU2003277416A patent/AU2003277416A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004035043A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003282478A1 (en) | Discount-instrument methods and systems | |
AU2003301680A1 (en) | Platinum complexes | |
AU2003202943A1 (en) | Flow sorting system and methods regarding same | |
AU2003286819A1 (en) | Alternate delivery location methods and systems | |
EP1573463A3 (en) | Alternate delivery location methods and systems | |
AUPS049102A0 (en) | Methods and systems (ap51) | |
AU2002952106A0 (en) | Methods and systems (npw008) | |
AUPS020302A0 (en) | Methods and systems (npw007) | |
AU2003243736A1 (en) | Improved assay systems and components | |
AU2003263747A1 (en) | Test system and methodology | |
AUPS048902A0 (en) | Methods and systems (ap49) | |
AU2003220350A1 (en) | Full bore selective location and orientation system | |
AU2002364051A1 (en) | Anti-cancer combination and use thereof | |
AUPS048802A0 (en) | Methods and systems (ap48) | |
AUPS048602A0 (en) | Methods and systems (ap46) | |
AUPS048402A0 (en) | Methods and systems (ap43) | |
AU2003210541A1 (en) | Health improvement systems and methods | |
AUPS047402A0 (en) | Methods and systems (ap65) | |
AUPS047502A0 (en) | Methods and systems (ap66) | |
AU2003231827A1 (en) | Pseudo-tissues and uses thereof | |
AUPS048302A0 (en) | Methods and systems (ap79) | |
AU2003277416A1 (en) | Clofarabine and platinum chemotherapy combination | |
AU2003302173A1 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
AUPS048202A0 (en) | Methods and systems (ap78) | |
AUPS047702A0 (en) | Methods and systems (ap68) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |